Ad is loading...
CRBU
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Nov 21 closing price
122 days until earnings call
NKTX
Price
$2.44
Change
-$0.06 (-2.40%)
Updated
Nov 21 closing price
118 days until earnings call
Ad is loading...

CRBU vs NKTX

Header iconCRBU vs NKTX Comparison
Open Charts CRBU vs NKTXBanner chart's image
Caribou Biosciences
Price$1.98
Change+$0.02 (+1.02%)
Volume$1.14M
CapitalizationN/A
Nkarta
Price$2.44
Change-$0.06 (-2.40%)
Volume$675.83K
CapitalizationN/A
CRBU vs NKTX Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRBU vs. NKTX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Sell and NKTX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (CRBU: $1.98 vs. NKTX: $2.44)
Brand notoriety: CRBU and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 94% vs. NKTX: 82%
Market capitalization -- CRBU: $179.29M vs. NKTX: $172.19M
CRBU [@Biotechnology] is valued at $179.29M. NKTX’s [@Biotechnology] market capitalization is $172.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and NKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 6 bearish.
  • NKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -5.26% price change this week, while NKTX (@Biotechnology) price change was -9.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 24, 2025.

NKTX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($179M) and NKTX($172M) have the same market capitalization . NKTX (-63.030) and CRBU (-65.445) have similar YTD gains . NKTX has higher annual earnings (EBITDA): -119.34M vs. CRBU (-161.7M). NKTX has more cash in the bank: 283M vs. CRBU (228M). CRBU has less debt than NKTX: CRBU (26.6M) vs NKTX (85.4M). CRBU has higher revenues than NKTX: CRBU (11.5M) vs NKTX (0).
CRBUNKTXCRBU / NKTX
Capitalization179M172M104%
EBITDA-161.7M-119.34M135%
Gain YTD-65.445-63.030104%
P/E RatioN/AN/A-
Revenue11.5M0-
Total Cash228M283M81%
Total Debt26.6M85.4M31%
TECHNICAL ANALYSIS
Technical Analysis
CRBUNKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGPSX82.171.33
+1.65%
ProFunds Mid Cap Growth Svc
ZDIIX27.350.31
+1.15%
Zacks Dividend Institutional
FDECX22.940.15
+0.66%
Fidelity Advisor Capital Development C
TFOAX74.280.19
+0.26%
Touchstone Focused A
PNGYX14.000.01
+0.07%
Putnam International Value Y

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with PGEN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-2.40%
PGEN - NKTX
49%
Loosely correlated
+7.91%
FATE - NKTX
49%
Loosely correlated
-6.76%
BCRX - NKTX
46%
Loosely correlated
+2.60%
ALLO - NKTX
45%
Loosely correlated
+2.93%
CRBU - NKTX
45%
Loosely correlated
+1.02%
More